Tenax Therapeutics, Inc. Healthcare | Biotechnology | USA Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company offers Wundecyte, a wound-healing gel. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Momentum looks good, think it goes up from here, but there is resistance around $2.43 (look at that volume on 10/5).
Beautiful close all things considering! Also for new people, News is NOT delayed - EOM was timeline given and many think next week.
The New York Times runs a science section every Tuesday and getting any sort of mention would be great for the stock. But an FDA affirmation announcement followed by a headline article in the Times would be a grand slam.
Cbis Canabis science is the next hot bull market stock medical marijuana is a billion dollar industry. Best move is to buy now while cheap. Hold for a investment for the future. Trtc is an another stock trending in the right direction.
No surprise this fell off a cliff, after failing at 2.43 resistance and the 3 previous days which failed to overtake the short-term moving average (eg 10 sma, or 8 ema).
CRAZY move! Tenax Therapeutics Announces New Scientific Publication of Preclinical Data Provides Additional Evidence of Levosimendan Treatment Effects in Pulmonary Hypertension - https://finance.yahoo.com/news/tenax-therapeutics-announces-scientific-publication-133000567.html